Sarepta Therapeutics Statistics
Total Valuation
SRPT has a market cap or net worth of $1.81 billion. The enterprise value is $2.09 billion.
| Market Cap | 1.81B |
| Enterprise Value | 2.09B |
Important Dates
The last earnings date was Wednesday, August 5, 2026, after market close.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRPT has 105.63 million shares outstanding. The number of shares has increased by 7.36% in one year.
| Current Share Class | 105.63M |
| Shares Outstanding | 105.63M |
| Shares Change (YoY) | +7.36% |
| Shares Change (QoQ) | -13.52% |
| Owned by Insiders (%) | 4.30% |
| Owned by Institutions (%) | 95.89% |
| Float | 91.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 31.03 |
| PS Ratio | 0.92 |
| Forward PS | 1.29 |
| PB Ratio | 1.19 |
| P/TBV Ratio | 1.21 |
| P/FCF Ratio | 22.17 |
| P/OCF Ratio | 16.35 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 25.52 |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.70.
| Current Ratio | 4.42 |
| Quick Ratio | 2.44 |
| Debt / Equity | 0.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | 12.98 |
| Interest Coverage | -2.00 |
Financial Efficiency
Return on equity (ROE) is -9.48% and return on invested capital (ROIC) is -3.36%.
| Return on Equity (ROE) | -9.48% |
| Return on Assets (ROA) | -1.13% |
| Return on Invested Capital (ROIC) | -3.36% |
| Return on Capital Employed (ROCE) | -5.33% |
| Weighted Average Cost of Capital (WACC) | 5.36% |
| Revenue Per Employee | $2.36M |
| Profits Per Employee | -$163,743 |
| Employee Count | 835 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.44 |
Taxes
In the past 12 months, SRPT has paid $5.81 million in taxes.
| Income Tax | 5.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.76% in the last 52 weeks. The beta is 0.20, so SRPT's price volatility has been lower than the market average.
| Beta (5Y) | 0.20 |
| 52-Week Price Change | -5.76% |
| 50-Day Moving Average | 16.89 |
| 200-Day Moving Average | 19.23 |
| Relative Strength Index (RSI) | 54.36 |
| Average Volume (20 Days) | 3,173,068 |
Short Selling Information
The latest short interest is 28.49 million, so 26.97% of the outstanding shares have been sold short.
| Short Interest | 28.49M |
| Short Previous Month | 28.73M |
| Short % of Shares Out | 26.97% |
| Short % of Float | 31.13% |
| Short Ratio (days to cover) | 7.12 |
Income Statement
In the last 12 months, SRPT had revenue of $1.97 billion and -$136.73 million in losses. Loss per share was -$1.32.
| Revenue | 1.97B |
| Gross Profit | -341.55M |
| Operating Income | -62.24M |
| Pretax Income | -130.92M |
| Net Income | -136.73M |
| EBITDA | -98.54M |
| EBIT | -143.25M |
| Loss Per Share | -$1.32 |
Balance Sheet
The company has $788.49 million in cash and $1.06 billion in debt, with a net cash position of -$273.92 million or -$2.59 per share.
| Cash & Cash Equivalents | 788.49M |
| Total Debt | 1.06B |
| Net Cash | -273.92M |
| Net Cash Per Share | -$2.59 |
| Equity (Book Value) | 1.53B |
| Book Value Per Share | 14.46 |
| Working Capital | 1.72B |
Cash Flow
In the last 12 months, operating cash flow was $111.01 million and capital expenditures -$29.16 million, giving a free cash flow of $81.85 million.
| Operating Cash Flow | 111.01M |
| Capital Expenditures | -29.16M |
| Depreciation & Amortization | 44.71M |
| Net Borrowing | -159.07M |
| Free Cash Flow | 81.85M |
| FCF Per Share | $0.77 |
Margins
Gross margin is -17.30%, with operating and profit margins of -3.15% and -6.93%.
| Gross Margin | -17.30% |
| Operating Margin | -3.15% |
| Pretax Margin | -6.63% |
| Profit Margin | -6.93% |
| EBITDA Margin | -4.99% |
| EBIT Margin | -7.26% |
| FCF Margin | 4.15% |
Dividends & Yields
SRPT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.36% |
| Shareholder Yield | -7.36% |
| Earnings Yield | -7.53% |
| FCF Yield | 4.51% |
Analyst Forecast
The average price target for SRPT is $22.09, which is 28.58% higher than the current price. The consensus rating is "Hold".
| Price Target | $22.09 |
| Price Target Difference | 28.58% |
| Analyst Consensus | Hold |
| Analyst Count | 24 |
| Revenue Growth Forecast (3Y) | -16.03% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 12, 2012. It was a reverse split with a ratio of 1:6.
| Last Split Date | Jul 12, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:6 |
Scores
SRPT has an Altman Z-Score of -0.07 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.07 |
| Piotroski F-Score | 4 |